Columbia Laboratories to Discuss Fourth Quarter and Full Year 2014 Financial Results on March 18th Conference Call

BOSTON, March 10, 2015 /PRNewswire/ -- The management team at Columbia Laboratories, Inc. CBRX will hold a conference call on March 18, 2015, to discuss financial results for the fourth quarter and full year ended December 31, 2014.  The call details are as follows:

The teleconference replay will be available approximately one hour after completion through Friday, March 27, 2015, at (877) 344-7529 (U.S.), (855) 669-9658 (Canada) or (412) 317-0088 (International). The conference ID for the replay is 10059982.  The archived webcast will be available for one year via the aforementioned URLs.

About Columbia Laboratories
Columbia Laboratories, Inc. has a successful heritage in developing women's health focused pharmaceutical products, including CRINONE® 8% (progesterone gel), that is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 additional countries worldwide.  Columbia is leveraging its pharmaceutical development, clinical trial manufacturing, and advanced analytical and consulting services to advance an internal pipeline while generating revenue from pharmaceutical industry customers.  For more information, please visit www.columbialabs.com.

CRINONE^® is a registered trademark of Actavis, Inc. in the U.S.

Contact:
MBS Value Partners
Katja Buhrer
+212 661 7004
katja.buhrer@mbsvalue.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/columbia-laboratories-to-discuss-fourth-quarter-and-full-year-2014-financial-results-on-march-18th-conference-call-300048505.html

SOURCE Columbia Laboratories, Inc.